MoneyWorks4Me

Granules India - Quaterly Results

09 Nov 2023 Evaluate
The quarter ended September 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 10094.15 millions.Profit saw a slight increase of 6.64%to Rs. 1161.57  millions from Rs. 1089.28 millions.Operating profit for the quarter ended September 2023 rose to 2096.71 millions as compared to 1894.13 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 10094.15 9635.77 4.76 18304.15 18849.34 -2.89 39312.00 32384.37 21.39
Other Income 12.50 37.52 -66.68 16.86 83.00 -79.69 99.32 175.11 -43.28
PBIDT 2096.71 1894.13 10.70 3668.81 3906.22 -6.08 8481.71 6621.60 28.09
Interest 176.46 83.60 111.08 324.34 127.99 153.41 386.74 163.52 136.51
PBDT 1920.25 1810.53 6.06 3344.47 3778.23 -11.48 8094.97 6458.08 25.35
Depreciation 360.12 348.68 3.28 712.79 694.67 2.61 1455.57 1261.61 15.37
PBT 1560.13 1461.85 6.72 2631.68 3083.56 -14.65 6639.40 5196.47 27.77
TAX 398.56 372.57 6.98 671.71 746.60 -10.03 1651.55 1331.31 24.05
Deferred Tax 29.85 -18.52 -261.18 47.39 -39.07 -221.30 -50.51 -3.76 1243.35
PAT 1161.57 1089.28 6.64 1959.97 2336.96 -16.13 4987.85 3865.16 29.05
Equity 242.37 248.29 -2.38 242.37 248.29 -2.38 242.04 248.01 -2.41
PBIDTM(%) 20.77 19.66 5.67 20.04 20.72 -3.28 21.58 20.45 5.52
Peers
Company Name CMP
Sun Pharma. Inds. 1854.05
Dr. Reddys Labs. 1197.75
Cipla 1380.00
Lupin 2093.00
Zydus Lifesciences 1158.25
View more..